

Durham, North Carolina and Austin-based Shattuck Labs Inc, a clinical-stage biotechnology company, has raised $118 million in Series B financing. The lead investor was Redmile Group.
Source: Press Release
Durham, North Carolina and Austin-based Shattuck Labs Inc, a clinical-stage biotechnology company, has raised $118 million in Series B financing.
Durham, North Carolina and Austin-based Shattuck Labs Inc, a clinical-stage biotechnology company, has raised $118 million in Series B financing. The lead investor was Redmile Group.
Source: Press Release
Copyright PEI Media
Not for publication, email or dissemination